Treatment modalities in deep venous thrombosis

With the results obtained, we concluded that, due to effectiveness and lower bleeding risk and application facility of low molecular weighted heparin, it began to replace standart heparins, and fibrinolytic therapy could be used in early cases because of succesful results, and that thrombectomy could still be applied in suitable cases.

📌 3 Key Takeaways

🎯

Objective & Hypothesis:The ratios of complications and recovery of heparinization applied to the patients diagnosed with deep venous thrombosis, fibrinolytic therapy, trombectomy and pulmoner embolectomy were examined retrospectively by the purpose of presenting the approach of the clinic of cardiovascular surgery of Atatürk University.

📊

Key Findings & Data:In treatment, low-molecule weighted heparin was used in 155 patients (44%), standart heparin was used in 173 patients (50%), fibrinolytic agents were used in 14 patients (4%).

💡

Conclusion & Impact:With the results obtained, we concluded that, due to effectiveness and lower bleeding risk and application facility of low molecular weighted heparin, it began to replace standart heparins, and fibrinolytic therapy could be used in early cases because of succesful results, and that thrombectomy could still be applied in suitable cases.

🔬Design:Research Article

📍Scope:Comprehensive Sample

⚙️Variables:Domain Parameters

Abstract

The ratios of complications and recovery of heparinization applied to the patients diagnosed with deep venous thrombosis, fibrinolytic therapy, trombectomy and pulmoner embolectomy were examined retrospectively by the purpose of presenting the approach of the clinic of cardiovascular surgery of Atatürk University. In treatment, low-molecule weighted heparin was used in 155 patients (44%), standart heparin was used in 173 patients (50%), fibrinolytic agents were used in 14 patients (4%). Pulmonary embolectomy was applied to 4 patients (1%) and ileofemoral trombectomy to 3 patients (1%). With the results obtained, we concluded that, due to effectiveness and lower bleeding risk and application facility of low molecular weighted heparin, it began to replace standart heparins, and fibrinolytic therapy could be used in early cases because of succesful results, and that thrombectomy could still be applied in suitable cases.

Özet

Bu çalışmada, Atatürk Üniversitesi Tıp Fakültesi Kalp-Damar Cerrahisi Kliniği'nin yaklaşımını aktarmak amacıyla, 3.3.95 ile 1.3.99 tarihleri arasında, derin ven trombozu tanısı ile tedavi gören hastalara uygulanan heparinizasyon, fibrinolitik tedavi, trombektomi ve pulmoner embolektomi yöntemlerinin şifa ve komplikasyon oranları retrospektif olarak incelendi. Tedavide 155 hastada (%44) düşük molekül ağırlıklı heparin, 173 hastada (%50) standart heparin, 14 hastada (%4) fibrinolitik ajanlar kullanıldı. 4 hastada pulmoner embolektomi (%1), 3 hastada (%1) ise ileofemoral trombektomi girişimi uygulandı. 7 vakada ise proflaktik amaçlı vena kava filtresi uygulandı. Elde edilen sonuçlar ile son zamanlarda kullanıma giren düşük molekül ağırlıklı heparinlerin uygulama kolaylığı, etkinliği ve kanama riskinin azlığı dolayısıyla standart heparinin yerini almaya başladığı, erken olgularda fibrinolitik tedavinin yüz güldürücü olduğu, uygun vakalarda trombektominin halen uygulanabileceği kanaatine varıldı.

🔖

Cite This Article

DAĞ, Ö., ÖZYAZICIOĞLU, A., ERKUT, B., CERRAHOĞLU, M., KOÇAK, H., YEKELER, İ., AÇIKEL, M. (2022). Treatment modalities in deep venous thrombosis. Türk Göğüs Kalp Damar Cerrahisi Dergisi, Cilt: 8 - Sayı: 3, 715–718. https://ajindex.com/articles/425623

📄 Full Text PDF Viewer

Open in New Tab ↗

↗New Tab

📄

PDF görüntüleyici hazırlanıyor...

References (1)

Kurtoðlu M, Taviloðlu K, Ertekin C. Derin ventrombozuna yaklaþým. Çaðdaþ Cerrahi Dergisi 1992; 6:162-5. 2.Thery C, Simonneau G, Meyer G, et al. Ramdomized trialof subcutaneous low-molecular-weight heparin CY 216 (Fraxiparine) compared with intravenous unfractionated heparin in the curative treatment of submassive pulmonaryembolism. Circulation 1992;85:1380-9. 3.Albrechtsson U, Anderson J, Einarsson E, et al. Streptokinase treatment of deep venous thrombosis and the postthrombotic syndrome. Arch surg 1981;116:33-7. 4.Verstraete M. Pharmacetherapeutic aspects of unfractionated and low molecular weight heparins. Drugs 1990;40: 498-530. 5.Kakkar VV, Murray W J G. Efficacy and safety of low-molecular-weight heparin (CY 216) in preventingpostoperative venous thrombo-embolism. A Co-OperativeStudy: Br J Surg 1985;72:786-91. 6.A Collabarative Europen Multicentre Study. Arandomized trial of subcutaneous low molecular weight heparin (CY 216) compared with intravenousunfractionated heparin in the treatment of deep vein thrombosis. Thromb Haemostas 1991;65:251-6. 7.Koopman Maria MW, Prandoni P, Piovella F, et al. Treatment of venous thrombosis with intravenousunfractionated heparin administered in the hospital as compared with subcutaneous low-molecular-weightheparin administered at home. Jn Eng Med 1996;334:682-7. 8.Yekeler İ, Ateþ A, Özyazýcýoðlu A, ve ark. Akut vasküler týkanmalarda fibrinolitik tedavi. AÜTD 1998;30:111-4. 9.Amery D, Dekoof W, Vermylen J, et al. Outcome of recentthromboembolic occlusions of limb arteries treated with streptokinase. Br J Med 1970;4:639-44. 10.Boysen G. Overview on thrombolysis in acute ischemic stroke. Fibrinolysis 1995;9:29-32. 11.Mattox KL, Feldtman RW, Beal AC, et al. Pulmonary embolectomy acut massive pulmonary embolism. AnnSurg 1982;195:726-31. 12.Goldhaber SZ, Morpurgo M. Pulmoner emboli. Taný, tedavi ve koruma. JAMA 1993;6:424-32. 13.Takahashi M, Tanaka N, Sawa S, et al. The results of threecases of unilateral pulmonary embolectomy through right thoracotomy apporach for chronic pulmonary embolisaJ Cardiovasc Surg 1995;36:195-8. 14.Grassi CJ, Goldhaber SZ. Interruption of the vena cava for the prevention of pulmonary embolism. Transvenous filter devices. Herz 1989;14:182-91. 15.Stuiz P, Schiapfer R, Feer R, et al. Decision making in thesurgical treatment of massive pulmonary embolism.Eur J Cardiothorac Surg 1994;8:188-93.